Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. SRX1

Sirtex Medical Limited (ASX: SRX1) - Share Price and Research

DELISTED

Intelligent Investor free trial for buy hold sell stock recommendations

SRX1 General Information +

ASX Code SRX1
Website N/A
Industry/Sector Biotechnology
Market Cap ($M) n/a
SRX1 Share Price N/A
Day High N/A
Day Low N/A
Last Close N/A
SRX1 Share Price Movement N/A
+Security prices are delayed by at least 20 minutes and are indicative only.
Trial Banner Trial Banner Trial Banner
Upsell Banner

SRX1 Related Research

Sirtex Medical Limited (SRX1) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 30¢ 0% 26 Sep 2017 18 Oct 2017 - - -
HFResult 30¢ 77.67% 27 Sep 2016 19 Oct 2016 - - -
HFResult 20¢ 100% 28 Sep 2015 21 Oct 2015 - - -

See all dividends from Sirtex Medical Limited (SRX1) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Sirtex Medical Limited (SRX1) Recent ASX Announcements

There are no announcements from Sirtex Medical Limited (SRX1). Please use our ASX Announcements tool to search for announcements across all ASX-listed securities.

SRX1 Directors

Name Position Start Date
Mr Andrew McLean Chief Executive Officer, Managing Director 16 Jun 2017
Dr Katherine Leslie Woodthorpe Non-Executive Director 22 Sep 2015
Mr Neville Mitchell Non-Executive Director 10 Apr 2017

Sirtex Medical Limited (SRX1) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
25 Aug 2017 WOODTHORPE, Katherine Buy Direct Shares 2,000 $14.800 $29,599.520
23 Aug 2017 MITCHELL, Neville Buy Indirect Shares 6,000 $14.566 $87,396.800
26 Oct 2016 WONG, Gilman Sell Direct Shares 74,968 $28.484 $2,135,378.370

See all changes in directors' interest & trades for Sirtex Medical Limited (SRX1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SRX1 Management

Name Position
Darren Smith Chief Financial Officer,Company Secretary
Kevin Smith Executive Vice President, Sales and Marketing, Americas
Anthony Dixon Executive Vice President, Sales and Marketing, EMEA
G Spindler Global Head of Operations

SRX1 Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (SRX1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
3,122,412 (5.60%) Morgan Stanley Asia
2,889,983 (5.18%) Bruce N Gray

FAQs about Sirtex Medical Limited (SRX1)

Relative to the previous close share price of , Sirtex Medical Limited's (SRX1) current share price of constitutes a movement of or . Sirtex Medical Limited's (SRX1) share price movement is when compared to 7 days ago and is n/a below SRX1's 52-week high of n/a.

Sirtex Medical Limited (SRX1) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for SRX1 is a ratio that tells you the percentage of Sirtex Medical Limited's (SRX1) share price that it pays out in dividends each year.

Sirtex Medical Limited (SRX1) last dividend payment was $0.30 per share and was paid on 18 Oct 2017. This last SRX1 dividend included 0% franking.

Sirtex Medical Limited (SRX1) will release its next Annual Report on n/a. Sirtex Medical Limited's (SRX1) last annual report was released on n/a.

Sirtex Medical Limited (SRX1) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.